GENE ONLINE|News &
Opinion
Blog

2025-11-28|

Study Finds Socioeconomic Status and Healthcare Access Impact Attendance at Autism Follow-Up Evaluations

by GOAI
Share To

A recent study conducted by Wieckowski et al. (2025) examines the factors influencing whether children attend follow-up evaluations after initial autism screenings. The research highlights that while autism screening is a critical first step in identifying children who may have autism, many families face barriers that prevent them from completing the diagnostic process. The study focuses on understanding these challenges and predicting attendance for post-screening evaluations.

The findings reveal several key factors affecting attendance rates, including socioeconomic status, access to healthcare resources, and parental awareness of the importance of follow-up care. Researchers analyzed data from families who participated in autism screenings and tracked their subsequent engagement with diagnostic services. The study underscores the complexity of navigating the path from screening to diagnosis and emphasizes how external factors can influence whether children receive timely evaluations. This research provides insight into potential gaps in support systems for families undergoing this process.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: November 29, 2025

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
AI-Driven Healthcare Transformation at Healthcare Expo Taiwan 2025
2025-12-05
LATEST
AI-Driven Healthcare Transformation at Healthcare Expo Taiwan 2025
2025-12-05
How AWS Cloud Is Transforming Global Smart Healthcare and Trusted Research Environments
2025-12-03
MedTex 2025: Taiwan as Gateway for AI-Driven Medical Innovation and Global Capital
2025-12-03
FDA CBER Director Vinay Prasad Issues November 2025 Memo Addressing Vaccine Development and Regulatory Challenges
2025-12-03
FDA to Review 16 Drug Applications Including 8 New Molecular Entities by Year-End
2025-12-03
Stephen Durso Named CEO of Altimmune Inc. as Vipin Garg Steps Down
2025-12-03
Janux Therapeutics Shares Halve Despite Positive Phase I Trial Results for Solid Tumor Therapy
2025-12-03
EVENT
2025-12-06
The 67th ASH Annual Meeting and Exposition
Orlando, Florida, USA
2025-12-04
2025 Healthcare+ Expo Taiwan
Taipei, Taiwan
Scroll to Top